TANG CAPITAL PARTNERS LP 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:00 pm Sale | 2024-12-31 | 13G | Outlook Therapeutics, Inc. OTLK | TANG CAPITAL PARTNERS LP | 1,682,502 6.400% | -533,349 (-24.07%) | Filing |
| 2024-03-28 4:00 pm Purchase | 2024-03-18 | 13G | Outlook Therapeutics, Inc. OTLK | TANG CAPITAL PARTNERS LP | 2,215,851 9.990% | 2,215,851 (New Position) | Filing |